Glioblastoma multiforme: pathology, natural history and treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D001254:Astrocytoma / Q000628:therapy; D001932:Brain Neoplasms / Q000473:pathology / Q000628:therapy*; D002330:Carmustine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005909:Glioblastoma / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008872:Microwaves; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D011838:Radiation-Sensitizing Agents; D011344:Procarbazine; D007372:Interferons; D011239:Prednisolone; D002330:Carmustine; D008775:Methylprednisolone